Together these results illustrate the structural impact of missense variants in both catalytic and non-catalytic PR-DUB components that are enriched in tumours, and show that the crystal structure of Calypso–ASX is a promising model for predicting the effects of mutations in the human BAP1–ASXL1/2 complexes. Here, ASXL1 is linked to neoplasm.